vimarsana.com

Metasploit Meterpreter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Expired Redis Service Abused to Use Metasploit Meterpreter Maliciously

Attackers have compromised an 8-year-old version of the cloud platform to distribute various malware that can take over infected systems.

New remote access exploit targets Windows Servers in Healthcare

Threat actors have successfully compromised ScreenConnect to exploit multiple Windows Server instances in the healthcare sector.

Multiple Nation-State Threat Actors Exploit CVE-2022-47966 and CVE-2022-42475

SUMMARY The Cybersecurity and Infrastructure Security Agency (CISA), Federal Bureau of Investigation (FBI), and Cyber National Mission Force (CNMF) identified the presence of indicators of compromise (IOCs) at an Aeronautical Sector organization as early as January 2023. Analysts confirmed that nation-state advanced persistent threat (APT) actors exploited CVE-2022-47966 to gain unauthorized access to a public-facing

Multiple Nation-State Threat Actors Exploit CVE-2022-47966 and CVE-2022-42475

SUMMARY The Cybersecurity and Infrastructure Security Agency (CISA), Federal Bureau of Investigation (FBI), and Cyber National Mission Force (CNMF) identified the presence of indicators of compromise (IOCs) at an Aeronautical Sector organization as early as January 2023. Analysts confirmed that nation-state advanced persistent threat (APT) actors exploited CVE-2022-47966 to gain unauthorized access to a public-facing

Multiple Nation-State Threat Actors Exploit CVE-2022-47966 and CVE-2022-42475

SUMMARY The Cybersecurity and Infrastructure Security Agency (CISA), Federal Bureau of Investigation (FBI), and Cyber National Mission Force (CNMF) identified the presence of indicators of compromise (IOCs) at an Aeronautical Sector organization as early as January 2023. Analysts confirmed that nation-state advanced persistent threat (APT) actors exploited CVE-2022-47966 to gain unauthorized access to a public-facing

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.